Lipopolysaccharide-regulated secretion of soluble and vesicle-based proteins from a panel of colorectal cancer cell lines.

Abstract

EXPERIMENTAL DESIGN

Cancer cell secretome was harvested in bio-duplicate after LPS treatment, and separated in EV and soluble secretome (SS) fractions. Gel-fractionated proteins were analysed by label-free nano-liquid chromatography coupled to tandem mass spectrometry. NF-κB activation, triggered upon LPS treatment, was evaluated.

RESULTS

We report a CRC secretome dataset of 5601 proteins. Comparison of all LPS-treated cells with controls revealed 37 proteins with altered abundance in the SS, including RPS25; and 13 in EVs, including HMGB1. Comparing controls and LPS-treated samples per cell line, revealed 564 significant differential proteins with fold-change > 3. The LPS-induced release of RPS25 was validated by western blot.

PURPOSE

To mimic the perioperative microenvironment where bacterial products get in contact with colorectal cancer (CRC) cells and study its impact on protein release, we exposed six CRC cell lines to lipopolysaccharide (LPS) and investigated the effect on the secretome using in-depth mass spectrometry-based proteomics.

CONCLUSIONS AND CLINICAL RELEVANCE

Bacterial endotoxin has minor impact on the global CRC cell line secretome yet it may alter protein release in a cell line-specific manner. This modulation might play a role in orchestrating the development of a permissive environment for CRC liver metastasis, especially through EV-communication. This article is protected by copyright. All rights reserved.

More about this publication

Proteomics. Clinical applications
  • Pages e1900119
  • Publication date 15-02-2021

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.